| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1817 | 2020 |
| Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ... The lancet oncology 22 (1), 107-117, 2021 | 260 | 2021 |
| Mortality in diabetes mellitus: experience of a geographically defined population JSK Wong, DWM Pearson, LE Murchison, MJ Williams, V Narayan Diabetic medicine 8 (2), 135-139, 1991 | 85 | 1991 |
| International diabetes federation NH Cho, D Whiting, L Guariguata, PA Montoya, N Forouhi, I Hambleton, ... IDF diabetes atlas 7, 11-129, 2017 | 62 | 2017 |
| A systematic assessment of Cochrane reviews and systematic reviews published in high-impact medical journals related to cancer M Goldkuhle, VM Narayan, A Weigl, P Dahm, N Skoetz BMJ open 8 (3), e020869, 2018 | 59 | 2018 |
| Novel biomarkers for prostate cancer: an evidence‐based review for use in clinical practice VM Narayan, BR Konety, C Warlick International Journal of Urology 24 (5), 352-360, 2017 | 45 | 2017 |
| Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia JH Jung, KA McCutcheon, M Borofsky, S Young, J Golzarian, MH Kim, ... Cochrane Database of Systematic Reviews, 2020 | 42 | 2020 |
| The impact of squamous histology on survival in patients with muscle-invasive bladder cancer JT Matulay, SL Woldu, A Lim, VM Narayan, G Li, AM Kamat, CB Anderson Urologic Oncology: Seminars and Original Investigations 37 (6), 353. e17-353 …, 2019 | 39 | 2019 |
| Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia JH Jung, B Reddy, KA McCutcheon, M Borofsky, V Narayan, MH Kim, ... Cochrane Database of Systematic Reviews, 2019 | 39 | 2019 |
| Contemporary outcomes of patients with nonmuscle-invasive bladder cancer treated with bacillus Calmette-Guérin: implications for clinical trial design JT Matulay, R Li, PJ Hensley, NA Brooks, VM Narayan, HB Grossman, ... The Journal of urology 205 (6), 1612-1621, 2021 | 36 | 2021 |
| The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality JL Han, S Gandhi, CG Bockoven, VM Narayan, P Dahm BJU international 119 (4), 638-649, 2017 | 35 | 2017 |
| The fragility of statistically significant findings from randomised controlled trials in the urological literature VM Narayan, S Gandhi, K Chrouser, N Evaniew, P Dahm BJU international 122 (1), 160-166, 2018 | 34 | 2018 |
| Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma MI Higgins, DJ Martini, DH Patil, R Nabavizadeh, S Steele, M Williams, ... Cancer 127 (12), 1974-1983, 2021 | 32 | 2021 |
| A critical appraisal of biomarkers in prostate cancer VM Narayan World journal of urology 38, 547-554, 2020 | 32 | 2020 |
| The prevalence and impact of urinary marker testing in patients with bladder cancer VM Narayan, O Adejoro, I Schwartz, M Ziegelmann, S Elliott, BR Konety The Journal of Urology 199 (1), 74-80, 2018 | 28 | 2018 |
| Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer P Maisch, A Koziarz, J Vajgrt, V Narayan, MH Kim, P Dahm Cochrane Database of Systematic Reviews, 2021 | 25 | 2021 |
| Clinical and genomic considerations for variant histology in bladder cancer JT Matulay, VM Narayan, AM Kamat Current oncology reports 21, 1-9, 2019 | 23 | 2019 |
| Intravesical gemcitabine for non‐muscle invasive bladder cancer MA Han, P Maisch, JH Jung, JE Hwang, V Narayan, A Cleves, EC Hwang, ... Cochrane Database of Systematic Reviews, 2021 | 22 | 2021 |
| Improved reporting of randomized controlled trials in the urologic literature VM Narayan, EB Cone, D Smith, CD Scales Jr, P Dahm European Urology 70 (6), 1044-1049, 2016 | 17 | 2016 |
| Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A … V Narayan, A Kahlmeyer, P Dahm, N Skoetz, MC Risk, C Bongiorno, ... Cochrane Database of Systematic Reviews, 2018 | 16 | 2018 |
Philipp DahmMinneapolis VAMC and University of Minnesota Department of UrologyVerified email at umn.edu
